Evaluation of pharmaceuticals and personal care products with emphasis on anthelmintics in human sanitary waste, sewage, hospital wastewater, livestock wastewater and receiving water

Journal of Hazardous Materials

Volumn 248-249, Issue 1, 2013, Pages 219-227

  Sim, Won Jin ^a,b   Kim, Hee Young ^a   Choi, Sung Deuk ^c   Kwon, Jung Hwan ^d   Oh, Jeong Eun ^a  

^a Pusan National University   (South Korea)

^b Korea Testing and Research Institute   (South Korea)

^c Ulsan National Institute of Science and Technology   (South Korea)

^d Korea University   (South Korea)

Author keywords

Anthelmintics; Human sanitary waste; Pharmaceuticals and personal care products; Receiving water; Wastewater

Indexed keywords

ALBENDAZOLE; ANIMAL BODY; ANTHELMINTICS; DISTRIBUTION PATTERNS; HOSPITAL WASTEWATER; LIVESTOCK WASTEWATER; NON-POINT SOURCE; OCCURRENCE PATTERN; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; POINT SOURCES; RECEIVING WATERS; RIVER WATER; TRANSFORMATION MECHANISMS; WASTE TREATMENT PLANT; WASTEWATER SOURCES; WASTEWATER TREATMENT PLANTS;

AGRICULTURE; BIOMOLECULES; METABOLITES; SEAWATER; SEWAGE PUMPING PLANTS; SEWAGE TREATMENT PLANTS; WASTE TREATMENT; WASTEWATER; WATER TREATMENT PLANTS;

EFFLUENTS;

ALBENDAZOLE; ANTHELMINTIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIPRURITIC AGENT; ATENOLOL; CAFFEINE; CARBAMAZEPINE; CLOFIBRIC ACID; COSMETIC; CROTAMITON; FENBENDAZOLE; FLUBENDAZOLE; GEMFIBROZIL; LINCOMYCIN; METOPROLOL; NONSTEROID ANTIINFLAMMATORY AGENT; OXFENDAZOLE; PROPRANOLOL; RIVER WATER; SEA WATER; SULFADIMIDINE; SULFAMERAZINE; SULFAMETHOXAZOLE; SULFAMONOMETHOXINE; SULFATHIAZOLE; TIABENDAZOLE; TRICLOSAN; TRIMETHOPRIM; UNINDEXED DRUG;

DAIRY FARMING; EFFLUENT; HOSPITAL SECTOR; METABOLITE; NONPOINT SOURCE POLLUTION; PHARMACEUTICAL INDUSTRY; SEWAGE; TRANSFORMATION; WATER TREATMENT;

ARTICLE; EVALUATION; HOSPITAL WASTE; LIVESTOCK; METABOLISM; METABOLITE; NONHUMAN; SEWAGE; SEWAGE TREATMENT PLANT; SOLID WASTE; WASTE WATER;

ANIMALS; ANTHELMINTICS; COSMETICS; ENVIRONMENTAL MONITORING; HOSPITALS; HUMANS; LIVESTOCK; MEDICAL WASTE; PHARMACEUTICAL PREPARATIONS; REPUBLIC OF KOREA; RIVERS; SEAWATER; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84873831020     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2013.01.007     Document Type: Article

References (34)

1. Clara M., Strenn B., Gans O., Martinez E., Kreuzinger N., Kroiss H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 2005, 39:4797-4807.
2. Kümmerer K. Antibiotics in the aquatic environment - a review - part I. Chemosphere 2009, 75:417-434.
3. Sanderson H., Johnson D.J., Reitsma T., Brain R.A., Wilson C.J., Solomon K.R. Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. Regul. Toxicol. Pharmacol. 2004, 39:158-183.
4. Brown K.D., Kulis J., Thomson B., Chapman T.H., Mawhinney D.B. Occurrence of antibiotics in hospital residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico. Sci. Total Environ. 2006, 366:772-783.
5. Jones O.A.H., Voulvoulis N., Lester J.N. The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilizing activated sludge treatment. Environ. Pollut. 2007, 145:738-744.
6. Kolpin D.W., Furlogn E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36:1202-1211.
7. Matamoros V., Bavona J.M. Elimination of pharmaceuticals and personal care products in subsurface flow constructed wetlands. Environ. Sci. Technol. 2006, 40:5811-5816.
8. Matamoros V., Hijosa M., Bayona J.M. Assessment of the pharmaceutical active compounds removal in wastewater treatment systems at enantiomeric level. Ibuprofen and naproxen. Chemosphere 2009, 75:200-205.
9. Pedrouzo M., Reverté S., Borrull F., Pocurull E., Marcé R.M. Pharmaceutical determination in surface and wastewaters using high-performance liquid chromatography-(electrospray)-mass spectrometry. J. Sep. Sci. 2007, 30:297-303.
10. Vanderford B.J., Pearson R.A., Rexing D.J., Snyder S.A. Analysis of endocrine disruptors pharmaceuticals, and personal care products in water using liquid chromatography/tandem mass spectrometry. Anal. Chem. 2003, 75:6265-6274.
11. Gabet-Giraud V., Miège C., Choubert J.M., Ruel S.M., Coquery M. Occurrence and removal of estrogens and beta blockers by various processes in wastewater treatment plants. Sci. Total Environ. 2010, 408:4257-4269.
12. Ort C., Lawrence M.G., Rieckermann J., Joss A. Sampling for pharmaceuticals and personal care products (PPCPs) and illicit drugs in wastewater systems: are your conclusions valid? A critical review. Environ. Sci. Technol. 2010, 44:6024-6035.
13. Van De Steene J.C., Stove C.P., Lambert W.E. A field study on 8 pharmaceuticals and 1 pesticide in Belgium: removal rates in waste water treatment plants and occurrence in surface water. Sci. Total Environ. 2010, 408:3448-3453.
14. Yang X., Flowers R.C., Weinberg H.S., Singer P.C. Occurrence and removal of pharmaceuticals and personal care products (PPCPs) in an advanced wastewater reclamation plant. Water Res. 2011, 45:5218-5228.
15. Capece B.P.S., Virkel G.L., Lanusse C.E. Enantiomeric behavior of albendazole and fenbendazole sulfoxides in domestic animals: pharmacological implications. Vet. J. 2009, 181:241-250.
16. Kim H.J., Lee D.S., Kwon J.H. Sorption of benzimidazole anthelmintics to dissolved organic matter surrogates and sewage sludge. Chemosphere 2010, 80:256-262.
17. Escher B.I., Berger C., Bramaz N., Kwon J.H., Richter M., Tsinman O., Avdeef A. Membrane-water partitioning membrane permeability, and baseline toxicity of the parasiticides ivermectin, albendazole, and morantel. Environ. Toxicol. Chem. 2008, 27:909-918.
18. Kreuzig R., Blumlein K., Holtge S. Fate of the benzimidazole antiparasitics flubendazole and fenbendazole in manure and manured solis. Clean - Soil Air Water 2007, 35:488-494.
19. Oh S.J., Park J., Lee M.J., Park S.Y., Lee J.H., Choi K. Ecological hazard assessment of major veterinary benzimidazoles: acute and chronic toxicities to aquatic microbes and invertebrates. Environ. Toxicol. Chem. 2006, 25:2221-2226.
20. Svendsen T.S., Hansen P.E., Sommer C., Martinussen T., Gronvold J., Holter P. Life history characteristics of Lumbricus terrestris and effects of the veterinary antiparasitic compounds ivermectin and fenbendazole. Soil Biol. Biochem. 2005, 37:927-936.
21. Kim Y., Jung J., Kim M., Park J., Boxall A.B.A., Choi K. Prioritizing veterinary pharmaceuticals for aquatic environment in Korea. Environ. Toxicol. Pharmacol. 2008, 26:167-176.
22. A.B.A. Boxall, L.A. Fogg, D.J. Baird, C. Lewis, T.C. Telfer, D. Kolpin, A. Gravell, E. Pemberton, T. Boucard, Targeted monitoring study for veterinarymedicines in the environment, UK Environment Agency, Bristol, Science Report SC030183/SR, 2005.
23. Capleton A.C., Courage C., Rumsby P., Holmes P., Stutt E., Boxall A.B.A., Levy L.S. Prioritising veterinarymedicines according to their potential indirect human exposure and toxicity profile. Toxicol. Lett. 2006, 163:213-223.
24. Weiss K., Schussler W., Porzelt M. Sulfamethazine and flubendazole in seepage water after the sprinkling of manured areas. Chemosphere 2008, 72:1292-1297.
25. Heggem B. Fenbendazole. J. Exot. Pet Med. 2008, 17:307-310.
26. McKellar Q.A., Gokbulut C., Muzandu K., Benchaoui H. Fenbendazole pharmacokinetics metabolism, and potentiation in horses. Drug Metab. Dispos. 2002, 30:1230-1239.
27. Sanyal P.K. The uptake of fenbendazole by cattle and buffalo following long-term low-level administration in urea-molasses blocks: further studies on block formulations. Vet. Res. Commun. 1993, 17:325-331.
28. Escher B.I., Fenner K. Recent advances in environmental risk assessment of transformation products. Environ. Sci. Technol. 2011, 45:3835-3847.
29. Halling-Sørensen B., Gengeløv G., Tjørnelund J. Toxicity of tetracyclines and tetracycline degradation products to environmentally relevant bacteria, including tetracycline-resistant bacteria. Arch. Environ. Contam. Toxicol. 2002, 42:263-271.
30. Kang H.J., Lim M.Y., Kwon J.H. Effects of adsorption onto silica sand particles on the hydrolysis of tetracycline antibiotics. J. Environ. Monit. 2012, 14:1853-1859.
31. Short C.R., Barker S.A., Flory W. Comparative drug metabolism and disposition in minor species. Vet. Hum. Toxicol. 1988, 30:2-8.
32. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D., Zuccato E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ. Sci. Technol. 2006, 40:357-363.
33. Sim W.J., Lee J.W., Oh J.E. Occurrence and fate of pharmaceuticals in wastewater treatment plants and rivers in Korea. Environ. Pollut. 2010, 158:1938-1947.
34. Sim W.J., Lee J.W., Lee E.S., Shin S.K., Hwang S.R., Oh J.E. Occurrence and distribution of pharmaceuticals in wastewater from households livestock farms, hospitals and pharmaceutical manufactures. Chemosphere 2011, 82:179-186.